Cargando…
Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease
BACKGROUND: The neurotransmitter serotonin (5‐HT) affects valvular degeneration and dogs with myxomatous mitral valve disease (MMVD) exhibit alterations in 5‐HT signaling. In Maltese dogs, 3 single nucleotide polymorphisms (SNPs) in the 5‐HT transporter (SERT) gene are suggested to associate with MM...
Autores principales: | Reimann, Maria J., Fredholm, Merete, Cremer, Signe E., Christiansen, Liselotte B., Meurs, Kathryn M., Møller, Jacob E., Häggström, Jens, Lykkesfeldt, Jens, Olsen, Lisbeth H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692205/ https://www.ncbi.nlm.nih.gov/pubmed/34599615 http://dx.doi.org/10.1111/jvim.16277 |
Ejemplares similares
-
No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan‐induced inhibition of platelet aggregation response
por: Reimann, Maria J., et al.
Publicado: (2023) -
Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
por: Christiansen, Liselotte B., et al.
Publicado: (2020) -
Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease
por: Christiansen, Liselotte B., et al.
Publicado: (2021) -
Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8‐ to 10‐Year Period
por: Birkegård, A.C., et al.
Publicado: (2016) -
Myoclonus in older Cavalier King Charles Spaniels
por: Rotter, Carina, et al.
Publicado: (2022)